Evidence map›Paper›PMID 33850732›Full record

ArticleToxicology reports2021

Amelioration of diethylnitrosamine (DEN) induced renal oxidative stress and inflammation by

Deepika Singh, Deepak Chaudhary, Vikas Kumar, Amita Verma

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Anti-carcinogenic effects and mechanisms of actions ofAmerican journal of cancer research · 2024
    Article
  9. Review
  10. Article
  11. Review
  12. Tackling of Renal Carcinogenesis in Wistar Rats byOxidative medicine and cellular longevity · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Deepika SinghDepartment of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh, 211007, India.
Deepak ChaudharyDepartment of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan, India.
Vikas KumarDepartment of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh, 211007, India.
Amita VermaDepartment of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh, 211007, India.
Sam Higginbottom Institute of Agriculture · INMohanlal Sukhadia University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInflammation and oxidative stress are the main factors ascribed with interruption in the process of renal tissue impairment. The toxicity of different types of nitrosamine is well recognized in animals and humans. Administration of the smallest quantities of diethylnitrosamine or dimethylnitrosamine either orally or parenterally results into renal damage. Therapeutic effects of phytofabricated silver nanoparticles of METHODOLOGY: Phytofabricated silver nanoparticles were characterized by using different instrumentation. Nephroprotective activity of silver nanoparticles at different doses was evaluated against N-diethylnitrosamine (200 mg/kg b.w., intraperitoneal) in animal model. Serum and renal homogenate were taken to evaluate the renal toxicity markers, oxidative stress, and antioxidant parameter, proinflammatory cytokines and histopathological study.

resultSignificant outcomes of silver nanoparticles in dose dependent manner down regulated the elevated serum marker, tumour marker enzymes and histopathology observation of repaired tissue assured the renal cancer activity in animals. In addition, profile of enzymatic and non-enzymatic antioxidant, proinflammatory cytokines and tumour promotion marker also favours the anticancer property of silver nanoparticles.

conclusionThe data of current study reveals silver nanoparticles ameliorates renal oxidative stress and carcinogenesis which was induced by N-diethylnitrosamine and accredited to antioxidant and anticancer activities of phytofabricated nanoparticles by biological approach.

Indexed as

ABTS, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acidAgNO3, silver nitrateAgNPs, silver nanoparticlesBUN, blood urea nitrogenCarissa carandas embedded silver nanoparticlesCCAgNPs, silver nanoparticles of carissa carandas aqueous extractCC, carissa carandasCDNB, 1-chloro-2,4-dinitrobenzeneDEN, diethylnitrosamineDLS, dynamic light scatteringDMN, dimethylnitrosamineDMSO, dimethyl sulphoxideFE-SEM, field emission scanning electron microscopyGGT, gamma glutamyl transpeptidaseGGT, γ-glutamyl transpeptidase activityGPx, glutathione peroxidaseGR, glutathione reductase activityGSH, glutathioneGST, glutathione –S- TransferaseH2O2, hydrogen peroxideIAEC, institutional animal ethical committeeLDH, lactate dehydrogenaseMDA, malondialdehydeNF-κB pathwayNPs, nanoparticlesODC, ornithine decarboxylaseRenal carcinomaROS, reactive oxygen speciesSOD, superoxide dismutaseXO, xanthine oxidase

Identifiers

PMID33850732
PMCPMC8039534
OpenAlexW3136694473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.